{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:story:566aa8d9-3162-4c0f-a4f8-d80a7204bb6f", "type": "composite", "version": "1", "versioncreated": "2026-08-20T19:42:21.693203Z", "firstcreated": "2026-08-20T19:42:21.693203Z", "pubstatus": "usable", "language": "fr", "headline": "Moderna saluée par Wall Street pour son vaccin à ARN messager contre le mélanome", "description_text": "Le laboratoire biotechnologique Moderna a vu son action bondir à Wall Street après la publication de résultats jugés prometteurs pour son traitement expérimental à ARN messager contre le cancer de la peau. Une avancée qui relance les espoirs d'une nouvelle génération de thérapies personnalisées.", "associations": {"item-0": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:27ab12cb-0bc1-4420-9768-6d50baee9808", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-21T19:24:31.484105Z", "firstcreated": "2026-08-20T19:11:21.693203Z", "pubstatus": "usable", "urgency": 5, "language": "fr", "headline": "Moderna saluée par Wall Street pour son vaccin à ARN messager contre le mélanome", "byline": "", "located": "France", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Nacrée", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Nacrée”. Set rel=canonical to https://nacree.org/monde/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome/ when publishing on the web.", "description_text": "Le laboratoire Moderna a vu son action bondir à Wall Street après l'annonce de résultats prometteurs pour son vaccin expérimental à ARN messager contre le cancer de la peau, une avancée saluée comme potentiellement révolutionnaire.", "altids": {"mosaic": "27ab12cb-0bc1-4420-9768-6d50baee9808", "story": "566aa8d9-3162-4c0f-a4f8-d80a7204bb6f", "slug": "moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome"}, "subject": [{"name": "World", "rel": "direct", "literal": "world", "code": "medtop:11000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/11000000"}], "place": [{"name": "France", "literal": "fr", "code": "FR", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:93c57f39-eff3-4bcf-8121-26c394c9c08a", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "Google Trends editorial task for France (FR, language fr).", "description_text": "Moderna saluée par Wall Street pour son vaccin à ARN messager contre le mélanome", "copyrightholder": "nbg1.your-objectstorage.com", "copyrightnotice": "Wireva desk", "usageterms": "Supplied with the copy; origin to be confirmed by the desk before redistribution.", "altids": {"wireva": "93c57f39-eff3-4bcf-8121-26c394c9c08a"}, "extra": {"wireva:delivery_mode": "preview_and_link", "wireva:rights": {"licence": "Desk-supplied", "licence_url": "", "licence_raw": "Manual upload", "licence_verified_at": "2026-08-21T20:23:37.982372Z", "attribution_required": true, "attribution_text": "Wireva desk", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "nbg1.your-objectstorage.com", "source_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-45-FR-2.jpg", "source_page_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-46-FR-2.jpg", "our_page_url": "https://reel.pink/actualites/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome-2/"}, "wireva:role": "lead"}, "renditions": {"preview": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/602b7359d597678aadf51110011b93a40caf5b853a8834095e0172db7f359b42.jpg", "mimetype": "image/jpeg", "width": 644, "height": 322}, "source": {"href": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-45-FR-2.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:566aa8d9-3162-4c0f-a4f8-d80a7204bb6f", "slug": "moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome-20260820", "status": "updated", "languages": ["fr"], "item_count": 4, "is_breaking": false}, "wireva:rights": {"class": "owned", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Nacrée", "canonical_required": true, "canonical_url": "https://nacree.org/monde/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "own_production", "needs_review": false}, "wireva:provenance": {"production_method": "ai_assisted", "ai_stages": {"editing": true, "drafting": true, "headline": true, "image_selection": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "unverified", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Cet article a été produit avec l’aide de l’IA sous la responsabilité éditoriale de Haydamax OU.", "independence_check": {"status": "not_applicable", "score": 0.0, "checked_at": "2026-08-21T20:23:37.847917Z"}, "sources": []}, "wireva:publication": {"name": "Nacrée", "domain": "nacree.org", "country": "FR", "url": "https://nacree.org/monde/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/27ab12cb-0bc1-4420-9768-6d50baee9808", "html": "https://wireva.mib.news/item/27ab12cb-0bc1-4420-9768-6d50baee9808/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome/", "story": "https://wireva.mib.news/story/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome-20260820/"}, "wireva:metrics": {"word_count": 624, "char_count": 4356, "reading_time_seconds": 311}}}, "item-1": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:b2031d0f-2b46-482d-b3bc-0d9ee02cc30e", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-21T19:24:31.413246Z", "firstcreated": "2026-08-20T19:13:59.214163Z", "pubstatus": "usable", "urgency": 5, "language": "fr", "headline": "Moderna saluée par Wall Street pour son traitement à ARN messager contre le mélanome", "byline": "", "located": "France", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Udata", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Udata”. Set rel=canonical to https://udata.stream/technologie/moderna-saluee-par-wall-street-pour-son-traitement-a-arn-messager-contre-le-melanome/ when publishing on the web.", "description_text": "Le laboratoire américain Moderna a vu son action bondir à Wall Street après l'annonce de résultats prometteurs pour son traitement expérimental à ARN messager contre le mélanome, un cancer de la peau agressif.", "altids": {"mosaic": "b2031d0f-2b46-482d-b3bc-0d9ee02cc30e", "story": "566aa8d9-3162-4c0f-a4f8-d80a7204bb6f", "slug": "moderna-saluee-par-wall-street-pour-son-traitement-a-arn-messager-contre-le-melanome"}, "subject": [{"name": "Technology", "rel": "direct", "literal": "technology", "code": "medtop:13000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/13000000"}], "place": [{"name": "France", "literal": "fr", "code": "FR", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:93c57f39-eff3-4bcf-8121-26c394c9c08a", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "Google Trends editorial task for France (FR, language fr).", "description_text": "Moderna saluée par Wall Street pour son vaccin à ARN messager contre le mélanome", "copyrightholder": "nbg1.your-objectstorage.com", "copyrightnotice": "Wireva desk", "usageterms": "Supplied with the copy; origin to be confirmed by the desk before redistribution.", "altids": {"wireva": "93c57f39-eff3-4bcf-8121-26c394c9c08a"}, "extra": {"wireva:delivery_mode": "preview_and_link", "wireva:rights": {"licence": "Desk-supplied", "licence_url": "", "licence_raw": "Manual upload", "licence_verified_at": "2026-08-21T20:23:37.982372Z", "attribution_required": true, "attribution_text": "Wireva desk", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "nbg1.your-objectstorage.com", "source_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-45-FR-2.jpg", "source_page_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-46-FR-2.jpg", "our_page_url": "https://reel.pink/actualites/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome-2/"}, "wireva:role": "lead"}, "renditions": {"preview": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/602b7359d597678aadf51110011b93a40caf5b853a8834095e0172db7f359b42.jpg", "mimetype": "image/jpeg", "width": 644, "height": 322}, "source": {"href": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-45-FR-2.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:566aa8d9-3162-4c0f-a4f8-d80a7204bb6f", "slug": "moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome-20260820", "status": "updated", "languages": ["fr"], "item_count": 4, "is_breaking": false}, "wireva:rights": {"class": "owned", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Udata", "canonical_required": true, "canonical_url": "https://udata.stream/technologie/moderna-saluee-par-wall-street-pour-son-traitement-a-arn-messager-contre-le-melanome/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "own_production", "needs_review": false}, "wireva:provenance": {"production_method": "ai_assisted", "ai_stages": {"editing": true, "drafting": true, "headline": true, "image_selection": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "unverified", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": false, "ai_disclosure_required": false, "ai_disclosure_text": "", "independence_check": {"status": "not_applicable", "score": 0.0, "checked_at": "2026-08-21T20:23:37.962772Z"}, "sources": []}, "wireva:publication": {"name": "Udata", "domain": "udata.stream", "country": "FR", "url": "https://udata.stream/technologie/moderna-saluee-par-wall-street-pour-son-traitement-a-arn-messager-contre-le-melanome/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/b2031d0f-2b46-482d-b3bc-0d9ee02cc30e", "html": "https://wireva.mib.news/item/b2031d0f-2b46-482d-b3bc-0d9ee02cc30e/moderna-saluee-par-wall-street-pour-son-traitement-a-arn-messager-contre-le-melanome/", "story": "https://wireva.mib.news/story/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome-20260820/"}, "wireva:metrics": {"word_count": 566, "char_count": 3922, "reading_time_seconds": 280}}}, "item-2": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:9c06da84-e4c1-4639-9312-e498b0877ff3", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-21T19:23:07.547828Z", "firstcreated": "2026-08-20T19:40:59.214163Z", "pubstatus": "usable", "urgency": 5, "language": "fr", "headline": "Moderna saluée par Wall Street pour son vaccin à ARN messager contre le mélanome", "byline": "", "located": "France", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Reel Pink", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Reel Pink”. Set rel=canonical to https://reel.pink/actualites/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome-2/ when publishing on the web.", "description_text": "Le laboratoire biotechnologique américain Moderna a vu son action bondir à la Bourse après la publication de résultats jugés prometteurs pour son traitement expérimental à ARN messager contre le cancer de la peau, suscitant un vif intérêt des investisseurs et de la communauté scientifique.", "altids": {"mosaic": "9c06da84-e4c1-4639-9312-e498b0877ff3", "story": "566aa8d9-3162-4c0f-a4f8-d80a7204bb6f", "slug": "moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome-2"}, "subject": [{"name": "General news", "rel": "direct", "literal": "general", "code": "medtop:11000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/11000000"}], "place": [{"name": "France", "literal": "fr", "code": "FR", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:93c57f39-eff3-4bcf-8121-26c394c9c08a", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "Google Trends editorial task for France (FR, language fr).", "description_text": "Moderna saluée par Wall Street pour son vaccin à ARN messager contre le mélanome", "copyrightholder": "nbg1.your-objectstorage.com", "copyrightnotice": "Wireva desk", "usageterms": "Supplied with the copy; origin to be confirmed by the desk before redistribution.", "altids": {"wireva": "93c57f39-eff3-4bcf-8121-26c394c9c08a"}, "extra": {"wireva:delivery_mode": "preview_and_link", "wireva:rights": {"licence": "Desk-supplied", "licence_url": "", "licence_raw": "Manual upload", "licence_verified_at": "2026-08-21T20:23:37.982372Z", "attribution_required": true, "attribution_text": "Wireva desk", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "nbg1.your-objectstorage.com", "source_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-45-FR-2.jpg", "source_page_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-46-FR-2.jpg", "our_page_url": "https://reel.pink/actualites/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome-2/"}, "wireva:role": "lead"}, "renditions": {"preview": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/602b7359d597678aadf51110011b93a40caf5b853a8834095e0172db7f359b42.jpg", "mimetype": "image/jpeg", "width": 644, "height": 322}, "source": {"href": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-45-FR-2.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:566aa8d9-3162-4c0f-a4f8-d80a7204bb6f", "slug": "moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome-20260820", "status": "updated", "languages": ["fr"], "item_count": 4, "is_breaking": false}, "wireva:rights": {"class": "owned", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Reel Pink", "canonical_required": true, "canonical_url": "https://reel.pink/actualites/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome-2/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "own_production", "needs_review": false}, "wireva:provenance": {"production_method": "ai_assisted", "ai_stages": {"editing": true, "drafting": true, "headline": true, "image_selection": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "unverified", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Cet article a été produit avec l’aide de l’IA sous la responsabilité éditoriale de Haydamax OU.", "independence_check": {"status": "not_applicable", "score": 0.0, "checked_at": "2026-08-21T20:23:37.980736Z"}, "sources": []}, "wireva:publication": {"name": "Reel Pink", "domain": "reel.pink", "country": "FR", "url": "https://reel.pink/actualites/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome-2/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/9c06da84-e4c1-4639-9312-e498b0877ff3", "html": "https://wireva.mib.news/item/9c06da84-e4c1-4639-9312-e498b0877ff3/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome-2/", "story": "https://wireva.mib.news/story/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome-20260820/"}, "wireva:metrics": {"word_count": 656, "char_count": 4479, "reading_time_seconds": 320}}}, "item-3": {"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:19d235df-9c7f-4a0f-a3ba-05b5d362c0c5", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-08-21T19:23:07.526419Z", "firstcreated": "2026-08-20T19:42:21.693203Z", "pubstatus": "usable", "urgency": 5, "language": "fr", "headline": "Moderna saluée par Wall Street pour son vaccin à ARN messager contre le mélanome", "byline": "", "located": "France", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Cortex", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Cortex”. Set rel=canonical to https://cortex.luxe/monde/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome/ when publishing on the web.", "description_text": "Le laboratoire biotechnologique Moderna a vu son action bondir à Wall Street après la publication de résultats jugés prometteurs pour son traitement expérimental à ARN messager contre le cancer de la peau. Une avancée qui relance les espoirs d'une nouvelle génération de thérapies personnalisées.", "altids": {"mosaic": "19d235df-9c7f-4a0f-a3ba-05b5d362c0c5", "story": "566aa8d9-3162-4c0f-a4f8-d80a7204bb6f", "slug": "moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome"}, "subject": [{"name": "World", "rel": "direct", "literal": "world", "code": "medtop:11000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/11000000"}], "place": [{"name": "France", "literal": "fr", "code": "FR", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:93c57f39-eff3-4bcf-8121-26c394c9c08a", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "Google Trends editorial task for France (FR, language fr).", "description_text": "Moderna saluée par Wall Street pour son vaccin à ARN messager contre le mélanome", "copyrightholder": "nbg1.your-objectstorage.com", "copyrightnotice": "Wireva desk", "usageterms": "Supplied with the copy; origin to be confirmed by the desk before redistribution.", "altids": {"wireva": "93c57f39-eff3-4bcf-8121-26c394c9c08a"}, "extra": {"wireva:delivery_mode": "preview_and_link", "wireva:rights": {"licence": "Desk-supplied", "licence_url": "", "licence_raw": "Manual upload", "licence_verified_at": "2026-08-21T20:23:37.982372Z", "attribution_required": true, "attribution_text": "Wireva desk", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "nbg1.your-objectstorage.com", "source_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-45-FR-2.jpg", "source_page_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-46-FR-2.jpg", "our_page_url": "https://reel.pink/actualites/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome-2/"}, "wireva:role": "lead"}, "renditions": {"preview": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/602b7359d597678aadf51110011b93a40caf5b853a8834095e0172db7f359b42.jpg", "mimetype": "image/jpeg", "width": 644, "height": 322}, "source": {"href": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-45-FR-2.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:566aa8d9-3162-4c0f-a4f8-d80a7204bb6f", "slug": "moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome-20260820", "status": "updated", "languages": ["fr"], "item_count": 4, "is_breaking": false}, "wireva:rights": {"class": "owned", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Cortex", "canonical_required": true, "canonical_url": "https://cortex.luxe/monde/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "own_production", "needs_review": false}, "wireva:provenance": {"production_method": "ai_assisted", "ai_stages": {"editing": true, "drafting": true, "headline": true, "image_selection": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "unverified", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Cet article a été produit avec l’aide de l’IA sous la responsabilité éditoriale de Haydamax OU.", "independence_check": {"status": "not_applicable", "score": 0.0, "checked_at": "2026-08-21T20:23:37.831102Z"}, "sources": []}, "wireva:publication": {"name": "Cortex", "domain": "cortex.luxe", "country": "FR", "url": "https://cortex.luxe/monde/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/19d235df-9c7f-4a0f-a3ba-05b5d362c0c5", "html": "https://wireva.mib.news/item/19d235df-9c7f-4a0f-a3ba-05b5d362c0c5/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome/", "story": "https://wireva.mib.news/story/moderna-saluee-par-wall-street-pour-son-vaccin-a-arn-messager-contre-le-melanome-20260820/"}, "wireva:metrics": {"word_count": 584, "char_count": 3977, "reading_time_seconds": 284}}}}, "extra": {"wireva:languages": ["fr"], "wireva:status": "updated", "wireva:item_count": 4}}